DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $779,034 | +115.7% | 3,140 | +108.6% | 0.04% | +10.5% |
| Q2 2023 | $361,200 | -5.4% | 1,505 | -0.7% | 0.04% | -9.5% |
| Q1 2023 | $381,840 | -6.6% | 1,515 | -1.6% | 0.04% | -8.7% |
| Q4 2022 | $408,746 | +2.4% | 1,540 | -0.3% | 0.05% | -4.2% |
| Q3 2022 | $399,000 | +1.5% | 1,545 | -0.3% | 0.05% | +9.1% |
| Q2 2022 | $393,000 | -15.8% | 1,550 | -2.6% | 0.04% | -6.4% |
| Q1 2022 | $467,000 | -16.0% | 1,591 | -5.9% | 0.05% | -11.3% |
| Q4 2021 | $556,000 | -29.8% | 1,690 | -35.0% | 0.05% | -34.6% |
| Q3 2021 | $792,000 | +12.2% | 2,602 | -1.1% | 0.08% | +11.0% |
| Q2 2021 | $706,000 | +15.0% | 2,630 | -3.7% | 0.07% | +9.0% |
| Q1 2021 | $614,000 | -7.4% | 2,730 | -8.5% | 0.07% | -10.7% |
| Q4 2020 | $663,000 | +1.1% | 2,985 | -2.0% | 0.08% | -10.7% |
| Q3 2020 | $656,000 | +18.0% | 3,045 | -3.2% | 0.08% | +10.5% |
| Q2 2020 | $556,000 | +23.8% | 3,145 | -3.1% | 0.08% | +8.6% |
| Q1 2020 | $449,000 | -16.4% | 3,245 | -7.2% | 0.07% | +1.4% |
| Q4 2019 | $537,000 | +6.3% | 3,496 | 0.0% | 0.07% | -1.4% |
| Q3 2019 | $505,000 | -1.6% | 3,496 | -2.6% | 0.07% | -4.1% |
| Q2 2019 | $513,000 | -8.4% | 3,591 | -15.3% | 0.07% | -12.0% |
| Q1 2019 | $560,000 | +14.8% | 4,241 | -10.4% | 0.08% | +2.5% |
| Q4 2018 | $488,000 | -9.0% | 4,735 | -4.1% | 0.08% | +2.5% |
| Q3 2018 | $536,000 | +10.1% | 4,935 | 0.0% | 0.08% | +5.3% |
| Q2 2018 | $487,000 | -3.0% | 4,935 | -3.8% | 0.08% | -5.1% |
| Q1 2018 | $502,000 | -4.0% | 5,130 | -8.9% | 0.08% | +1.3% |
| Q4 2017 | $523,000 | +15.5% | 5,630 | +6.6% | 0.08% | +11.4% |
| Q3 2017 | $453,000 | +1.6% | 5,280 | 0.0% | 0.07% | -1.4% |
| Q2 2017 | $446,000 | -7.5% | 5,280 | -6.2% | 0.07% | -10.1% |
| Q1 2017 | $482,000 | +4.6% | 5,630 | -4.9% | 0.08% | -2.5% |
| Q4 2016 | $461,000 | +1.1% | 5,921 | +1.7% | 0.08% | -2.4% |
| Q3 2016 | $456,000 | -26.2% | 5,821 | -4.8% | 0.08% | -26.5% |
| Q2 2016 | $618,000 | +4.0% | 6,117 | -2.3% | 0.11% | 0.0% |
| Q1 2016 | $594,000 | -4.7% | 6,260 | -6.7% | 0.11% | -5.8% |
| Q4 2015 | $623,000 | +9.5% | 6,710 | +0.4% | 0.12% | +3.4% |
| Q3 2015 | $569,000 | +0.5% | 6,680 | +1.1% | 0.12% | +10.5% |
| Q2 2015 | $566,000 | +22.0% | 6,610 | +20.8% | 0.10% | +22.1% |
| Q1 2015 | $464,000 | -4.5% | 5,470 | -3.5% | 0.09% | -2.3% |
| Q4 2014 | $486,000 | +3.2% | 5,670 | -8.5% | 0.09% | -1.1% |
| Q3 2014 | $471,000 | -3.3% | 6,195 | +0.1% | 0.09% | -4.3% |
| Q2 2014 | $487,000 | +6.6% | 6,190 | +1.6% | 0.09% | +1.1% |
| Q1 2014 | $457,000 | +73.1% | 6,090 | +78.1% | 0.09% | +53.3% |
| Q4 2013 | $264,000 | +15.8% | 3,420 | +4.0% | 0.06% | +5.3% |
| Q3 2013 | $228,000 | -11.6% | 3,290 | -19.2% | 0.06% | -17.4% |
| Q2 2013 | $258,000 | – | 4,070 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |